NORTHERN TRUST CORP - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 239 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$23,739,209
-10.0%
621,608
-3.0%
0.01%0.0%
Q2 2023$26,363,919
-31.0%
640,990
-3.7%
0.01%
-37.5%
Q1 2023$38,216,229
+0.4%
665,672
-1.9%
0.01%0.0%
Q4 2022$38,059,868
+31.8%
678,792
-0.4%
0.01%
+14.3%
Q3 2022$28,868,000
-17.5%
681,497
+5.3%
0.01%0.0%
Q2 2022$34,971,000
-17.7%
647,260
-2.1%
0.01%0.0%
Q1 2022$42,496,000
-5.5%
661,306
-1.5%
0.01%0.0%
Q4 2021$44,992,000
-4.0%
671,626
-1.9%
0.01%
-12.5%
Q3 2021$46,877,000
-2.4%
684,542
-2.7%
0.01%0.0%
Q2 2021$48,011,000
-3.8%
703,565
-2.6%
0.01%
-11.1%
Q1 2021$49,895,000
+9.5%
722,162
+2.9%
0.01%0.0%
Q4 2020$45,559,000
+37.5%
701,775
+0.0%
0.01%
+28.6%
Q3 2020$33,136,000
-1.3%
701,724
-1.8%
0.01%
-12.5%
Q2 2020$33,580,000
+6.7%
714,610
+1.4%
0.01%
-11.1%
Q1 2020$31,471,000
-20.1%
704,512
+4.2%
0.01%0.0%
Q4 2019$39,396,000
-1.1%
675,980
+1.9%
0.01%
-10.0%
Q3 2019$39,847,000
+4.1%
663,344
-3.2%
0.01%
+11.1%
Q2 2019$38,263,000
+2.8%
685,098
+2.6%
0.01%0.0%
Q1 2019$37,212,000
+35.8%
667,836
+9.9%
0.01%
+12.5%
Q4 2018$27,409,000
-30.8%
607,714
+1.1%
0.01%
-20.0%
Q3 2018$39,581,000
-6.3%
600,915
-8.3%
0.01%
-9.1%
Q2 2018$42,231,000
-11.8%
655,660
-24.2%
0.01%
-8.3%
Q1 2018$47,868,000
+14.9%
864,957
-0.6%
0.01%
+9.1%
Q4 2017$41,656,000
-7.2%
870,377
-2.1%
0.01%
-8.3%
Q3 2017$44,866,000
-7.6%
888,767
-0.2%
0.01%
-14.3%
Q2 2017$48,558,000
+37.2%
890,812
+6.1%
0.01%
+40.0%
Q1 2017$35,389,000
-5.8%
839,988
+91.9%
0.01%
-16.7%
Q4 2016$37,556,000
+16.2%
437,764
+11.8%
0.01%
+20.0%
Q3 2016$32,328,000
+9.1%
391,601
+5.5%
0.01%0.0%
Q2 2016$29,620,000
+34.3%
371,284
+13.1%
0.01%
+42.9%
Q1 2016$22,047,000
-0.1%
328,194
+0.8%
0.01%0.0%
Q4 2015$22,071,000
+14.5%
325,636
+0.6%
0.01%
+16.7%
Q3 2015$19,273,000
+3.1%
323,651
+16.6%
0.01%0.0%
Q2 2015$18,697,000
+3.4%
277,532
-5.4%
0.01%
+20.0%
Q1 2015$18,079,000
+14.2%
293,243
+0.4%
0.01%0.0%
Q4 2014$15,837,000
+3.8%
292,028
-5.0%
0.01%0.0%
Q3 2014$15,259,000
+8.6%
307,378
+2.9%
0.01%
+25.0%
Q2 2014$14,052,000
-5.2%
298,614
-7.3%
0.00%
-20.0%
Q1 2014$14,823,000
-8.8%
322,290
-5.4%
0.01%0.0%
Q4 2013$16,250,000
+34.7%
340,606
+13.6%
0.01%
+25.0%
Q3 2013$12,067,000
+8.6%
299,796
-1.2%
0.00%0.0%
Q2 2013$11,115,000303,4290.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q3 2020
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders